Effects of anti-IL 17 on inflammation in Asthma, COPD and Asthma-COPD models

F. Almeida (São Paulo (SP), Brazil), L. Camargo (São Paulo (SP), Brazil), N. Martins (São Paulo (SP), Brazil), J. Lourenço (São Paulo (SP), Brazil), S. Bezerra (São Paulo (SP), Brazil), B. Saraiva-Romanholo (São Paulo (SP), Brazil), E. Leick (São Paulo (SP), Brazil), F. Q.S. Lopes (São Paulo (SP), Brazil), C. Prado (Santos (SP), Brazil), R. Righetti (São Paulo (SP), Brazil), I. Tibério (São Paulo (SP), Brazil)

Source: International Congress 2022 – Clinical and translational studies of asthma and COPD: novel mechanisms

Session: Clinical and translational studies of asthma and COPD: novel mechanisms
Session type: Oral Presentation
Number: 2255

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Almeida (São Paulo (SP), Brazil), L. Camargo (São Paulo (SP), Brazil), N. Martins (São Paulo (SP), Brazil), J. Lourenço (São Paulo (SP), Brazil), S. Bezerra (São Paulo (SP), Brazil), B. Saraiva-Romanholo (São Paulo (SP), Brazil), E. Leick (São Paulo (SP), Brazil), F. Q.S. Lopes (São Paulo (SP), Brazil), C. Prado (Santos (SP), Brazil), R. Righetti (São Paulo (SP), Brazil), I. Tibério (São Paulo (SP), Brazil). Effects of anti-IL 17 on inflammation in Asthma, COPD and Asthma-COPD models. 2255

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.